Rothschild Investment LLC’s ANI Pharmaceuticals ANIP Stock Holding History

Rothschild Investment LLC’s Portfolio ANIP Stock Details ANIP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.4K	Buy	29 +3	+12%	+$241	﹤0.01%	2682
2026 Q1	$2K	Buy	26 +6	+30%	+$468	﹤0.01%	2564
2025 Q4	$1.58K	Hold	20	–	–	﹤0.01%	2484
2025 Q3	$1.83K	Hold	20	–	–	﹤0.01%	2283
2025 Q2	$1.3K	Sell	20 -10	-33%	-$651	﹤0.01%	2320
2025 Q1	$2.01K	Buy	30 +15	+100%	+$896	﹤0.01%	1896
2024 Q4	$829	Hold	15	–	–	﹤0.01%	2324
2024 Q3	$895	Buy	15 +10	+200%	+$610	﹤0.01%	2248
2024 Q2	$318	Buy	+5	New	+$325	﹤0.01%	2267
2020 Q2	–	Sell	-5,063	Closed	-$206K	–	427
2020 Q1	$206K	Sell	5,063 -4,493	-47%	-$239K	0.03%	369
2019 Q4	$589K	Buy	+9,556	New	+$633K	0.06%	272

Other funds holding ANIP

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

GACM

Global Alpha Capital Management Montreal, Quebec, Canada $1.67B AUM 35.09% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Rothschild Investment LLC's ANIP Position: Q2 2026 in Review

Rothschild Investment LLC increased its ANI Pharmaceuticals (ANIP) stake by 12% in Q2 2026, buying an estimated $241 and bringing the position to 29 shares worth $2.4K. The position accounts for ﹤0.01% of the portfolio, ranked #2682.

Rothschild Investment LLC first reported a position in ANIP in Q4 2019 and has held it in 11 quarters since. The position peaked at $589K in Q4 2019. 307 funds tracked by Wall St. Rank hold ANIP as of Q2 2026.

Rothschild Investment LLC held 29 shares of ANI Pharmaceuticals worth $2.4K as of Q2 2026.
Rothschild Investment LLC bought 3 ANI Pharmaceuticals shares in Q2 2026, an estimated $241.
ANI Pharmaceuticals made up ﹤0.01% of Rothschild Investment LLC's portfolio in Q2 2026, its #2682 holding.
Rothschild Investment LLC first reported a position in ANI Pharmaceuticals in Q4 2019 and has held it in 11 quarters since.
Rothschild Investment LLC's ANI Pharmaceuticals position peaked at $589K in Q4 2019.
307 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q2 2026.

Based on Rothschild Investment LLC's 13F filing for Q2 2026, filed 6 Aug 2026.